AAAAAA

   
Results: 1-9 |
Results: 9
Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin
Authors: Matsuoka, N Ogawa, Y Masuzaki, H Ebihara, K Aizawa-Abe, M Satoh, N Ishikawa, E Fujisawa, Y Kosaki, A Yamada, K Kuzuya, H Nakao, K
Citation: N. Matsuoka et al., Decreased triglyceride-rich lipoproteins in transgenic skinny mice overexpressing leptin, AM J P-ENDO, 280(2), 2001, pp. E334-E339
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. (vol 50, pg 1440, 2001)
Authors: Ebihara, K Ogawa, Y Masuzaki, H Shintani, M Miyanaga, F Aizawa-Abe, M Hayashi, T Hosoda, K Inoue, G Yoshimasa, Y Gavrilova, O Reitman, ML Nakao, K
Citation: K. Ebihara et al., Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. (vol 50, pg 1440, 2001), DIABETES, 50(7), 2001, pp. 1675-1675
Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes
Authors: Ebihara, K Ogawa, Y Masuzaki, H Shintani, M Miyanaga, F Aizawa-Abe, M Hayashi, T Hosoda, K Inoue, G Yoshimasa, Y Gavrilova, O Reitman, ML Nakao, K
Citation: K. Ebihara et al., Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes, DIABETES, 50(6), 2001, pp. 1440-1448
Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway
Authors: Shintani, M Ogawa, Y Ebihara, K Aizawa-Abe, M Miyanaga, F Takaya, K Hayashi, T Inoue, G Hosoda, K Kojima, M Kangawa, K Nakao, K
Citation: M. Shintani et al., Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway, DIABETES, 50(2), 2001, pp. 227-232
Pathophysiological role of leptin in obesity-related hypertension
Authors: Aizawa-Abe, M Ogawa, Y Masuzaki, H Ebihara, K Satoh, N Iwai, H Matsuoka, N Hayashi, T Hosoda, K Inoue, G Yoshimasa, Y Nakao, K
Citation: M. Aizawa-abe et al., Pathophysiological role of leptin in obesity-related hypertension, J CLIN INV, 105(9), 2000, pp. 1243-1252
Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin
Authors: Yura, S Ogawa, Y Sagawa, N Masuzaki, H Itoh, H Ebihara, K Aizawa-Abe, M Fujii, S Nakao, K
Citation: S. Yura et al., Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin, J CLIN INV, 105(6), 2000, pp. 749-755
Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin
Authors: Ogawa, Y Masuzaki, H Hosoda, K Aizawa-Abe, M Suga, J Suda, M Ebihara, K Iwai, H Matsuoka, N Satoh, N Odaka, H Kasuga, H Fujisawa, Y Inoue, G Nishimura, H Yoshimasa, Y Nakao, K
Citation: Y. Ogawa et al., Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin, DIABETES, 48(9), 1999, pp. 1822-1829
Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal Yellow agouti mutation - Usefulness of leptin for thetreatment of obesity-associated diabetes
Authors: Masuzaki, H Ogawa, Y Aizawa-Abe, M Hosoda, K Suga, J Ebihara, K Satoh, N Iwai, H Inoue, G Nishimura, H Yoshimasa, Y Nakao, K
Citation: H. Masuzaki et al., Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal Yellow agouti mutation - Usefulness of leptin for thetreatment of obesity-associated diabetes, DIABETES, 48(8), 1999, pp. 1615-1622
Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action
Authors: Ebihara, K Ogawa, Y Katsuura, G Numata, Y Masuzaki, H Satoh, N Tamaki, M Yoshioka, T Hayase, M Matsuoka, N Aizawa-Abe, M Yoshimasa, Y Nakao, K
Citation: K. Ebihara et al., Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action, DIABETES, 48(10), 1999, pp. 2028-2033
Risultati: 1-9 |